MO3-10-3Sustained fever associated with immune checkpoint inhibitors may be a poor prognostic factor

Abstract Immune-checkpoint inhibitors (ICIs) have been established as novel standard treatment for various types of malignancies, and immune-related adverse events (irAEs) are frequently observed with ICIs. This study aimed to evaluate whether fever associated with ICIs correlates with treatment res...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of oncology 2019-10, Vol.30 (Supplement_6)
Hauptverfasser:	Ueda, Hiroki, Murakami, Eriko, Okuda, Yuka, Takase, Eri, Kaki, Takahiro, Harutani, Yuhei, Yamagata, Nao, Furuta, Katsuyuki, Shimono, Chigusa, Yamamoto, Nobuyuki
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!